STATE STREET CORP - MYMD PHARMACEUTICALS INC ownership

MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 30 filers reported holding MYMD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of MYMD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$71,189
-60.5%
120,2520.0%0.00%
Q2 2023$180,378
-12.8%
120,2520.0%0.00%
Q1 2023$206,833
-11.6%
120,252
-40.9%
0.00%
Q4 2022$234,030
-12.0%
203,504
+100.0%
0.00%
Q3 2022$266,000
+20.4%
101,7520.0%0.00%
Q2 2022$221,000
-53.4%
101,7520.0%0.00%
Q1 2022$474,000
-4.0%
101,752
+24.7%
0.00%
Q4 2021$494,000
-15.8%
81,5860.0%0.00%
Q3 2021$587,000
+257.9%
81,586
+213.0%
0.00%
Q2 2021$164,00026,0630.00%
Other shareholders
MYMD PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Shay Capital LLC 139,986$365,0000.08%
Taylor & Morgan Wealth Management, LLC 17,086$45,0000.04%
Bridgecreek Investment Management, LLC 65,000$170,0000.04%
Corundum Group, Inc. 19,600$51,0000.03%
Aaron Wealth Advisors LLC 50,000$131,0000.02%
M Holdings Securities, Inc. 70,909$185,0000.02%
Cambria Investment Management, L.P. 65,398$171,0000.02%
Praetorian Wealth Management, Inc. 15,000$39,0000.02%
Mirae Asset Global Investments Co., Ltd. 638,580$1,667,0000.00%
Western Wealth Management, LLC 25,050$71,0000.00%
View complete list of MYMD PHARMACEUTICALS INC shareholders